TAT-GluN2BCTM
TAT-GluN2BCTM is a membrane-permeable DAPK1-targeting peptide. TAT-GluN2BCTM targets active DAPK1 to lysosomes for degradation. TAT-GluN2BCTM protects neurons from oxidative stress and NMDAR-mediated excitotoxicity by knocking down DAPK1. TAT-GluN2BCTM can be used in the study of neuroprotection.
For research use only. We do not sell to patients.
- CAS No.: 1587742-50-4
- Formula: C224H374N86O54
- Molecular Weight:5135.91
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
IC50 & Target
DAPK1[1].
In Vitro
TAT-GluN2BCTM (200 µM; 0.5, 2, 4 h) results in a time-dependent reduction in DAPK1 levels in NMDA-treated primary neuronal cultures [1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:primary neuronal cultures (NMDA-treated)
-
Concentration:200 µM
-
Incubation Time:0.5, 2, 4 h
-
Result:Reduced DAPK1 levels in a time-dependent manner.
In Vivo
TAT-GluN2BCTM (10 mg/kg; i.v.; single) shows prominent neuroprotection in the cortex and striatum of rats[1].
TAT-GluN2BCTM is capable of specific knockdown of the active (but not inactive) form of DAPK1[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Focal ischemia rat model[1].
-
Dosage:10 mg/kg
-
Administration:Intravenous injection; single.
-
Result:Reduced the levels of DAPK1 only in the ischemic side of the brain.
Significantly reduced the numbers of degenerating neurons in both striatum and cortical areas.
Chemical Information
-
CAS No. 1587742-50-4
-
Molecular Weight 5135.91
-
Formula C224H374N86O54
-
Sequence
Tyr-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-Lys-Lys-Asn-Arg-Asn-Lys-Leu-Arg-Arg-Gln-His-Ser-Tyr-Lys-Phe-Glu-Arg-Gln-Lys-Ile-Leu-Asp-Gln-Arg-Phe-Phe-Glu
-
Sequence Shortening
YGRKKRRQRRRKKNRNKLRRQHSYKFERQKILDQRFFE
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
ROS/oxidative-stress fluorescent staining
ROS/oxidative-stress fluorescent staining uses cell-permeant fluorogenic probes that become fluorescent after oxidation inside cells or tissues; commonly used examples include DCFH-DA/DCFDA for broad cellular oxidant detection, DHE for superoxide-related signal detection, MitoSOX for mitochondrial superoxide-related signal detection, and CellROX probes for oxidative-stress-associated fluorescence readouts. The assay detects probe oxidation rather than a single ROS species unless the probe and analysis method have been chemically validated for that species. DCFH-DA enters cells, is deacetylated by intracellular esterases to DCFH, and produces fluorescent DCF after oxidation, so the readout is used as an operational measure of total cellular oxidative stress rather than a species-specific ROS measurement. DHE and MitoSOX can report superoxide-related oxidation, but red fluorescence alone can include non-specific ethidium-like oxidation products; HPLC or optimized spectral approaches are
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)